Roche Gets Conditional EU Approval for Basal Cell Carcinoma DrugRoche Gets Conditional EU Approval for Basal Cell Carcinoma Drug

Roche said it had received conditional approval from the European Commission for Erivedge (vismodegib), for adults with metastatic BCC or locally advanced BCC inappropriate for surgery or radiotherapy. International Approvals
Source: Medscape Medical News Headlines - Category: Consumer Health News Tags: Hematology-Oncology News Alert Source Type: news